Ruipeng Song

3.6k citations
51 papers · 1.7k indexed · h-index 22
Topics
Cancer-related molecular mechanisms research (6 papers)Spine and Intervertebral Disc Pathology (6 papers)RNA modifications and cancer (5 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Ruipeng Song

49 papers receiving 1.6k citations

Peers

Ruipeng Song
Comparison fields: 5 of 114
  • Molecular Biology 997
  • Cancer Research 651
  • Oncology 275
  • Surgery 178
  • Pathology and Forensic Medicine 174
Replace Wan‐Chun Li with:
Wan‐Chun Li Taiwan
Ye Cheng China
Zhiwei Quan China
Yun Hong China
Guishuai Lv China
Hang Zheng China
Xue Zhao China
Vincent W.S. Liu Hong Kong
Federica Papaccio Italy
Dandan Wang China
Ruipeng Song relative to Wan‐Chun Li Taiwan Wan‐Chun Li's profile →
Citations per field
00.5×1.5×2.3×
Wan‐Chun Li · 1×
Citations per year

Countries citing papers authored by Ruipeng Song

Since Specialization
Citations

This map shows the geographic impact of Ruipeng Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruipeng Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruipeng Song more than expected).

Fields of papers citing papers by Ruipeng Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruipeng Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruipeng Song. The network helps show where Ruipeng Song may publish in the future.

Co-authorship network of co-authors of Ruipeng Song

This figure shows the co-authorship network connecting the top 25 collaborators of Ruipeng Song. A scholar is included among the top collaborators of Ruipeng Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruipeng Song. Ruipeng Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 3
5 2
6 2
7 1
8 3
9 10
10 12
11 1
12 2
13 2
14 212
15
Protective effect of vitamin B1 on diabetic peripheral neuropathy (DPN) and its mechanism
1
16 11
17 21
18 8
19 46
20 244

About Ruipeng Song

Ruipeng Song is a scholar working on Cancer Research, Hepatology and Pathology and Forensic Medicine, having authored 51 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Spine and Intervertebral Disc Pathology (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (651 citations), Hepatology (125 citations) and Molecular Biology (997 citations). Ruipeng Song has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jiabei Wang, Yingjian Liang, Tongsen Zheng, Shangha Pan, Hongchi Jiang, Dalong Yin, Lianxin Liu, Xuan Song, Lianxin Liu and Jihua Han. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026